Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study
NCT01616992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2015-02-04
Summary
Interstitial cystitis/painful bladder syndrome (IC/PBS) causes severe bladder pain and extensive disability in a large group of women int he prime of their productive lives. Extensive study of the bladder itself has uncovered many abnormalities, but the investigators do not know if these are the cause or result of the disorder. None of these has led to any real long-term progress in treatment, so far. The investigators have found that other autonomic disorders often occur in both the patients themselves and in the family members of patients with IC/PBS. The investigators therefore propose to determine whether the main abnormality in IC/PBS actually lies in the autonomic nervous system, rather than the bladder. The investigators will do this through careful measurements of autonomic function and sensation in patients who have IC/PBS, both at rest, and under controlled psychological stress. The investigators will compare their measurements to patients with myofascial pelvic pain, to know which abnormalities are truly linked to IC/PBS, and which simply reflect the presence of pelvic pain.
Conditions
- Interstitial Cystitis/Painful Bladder Syndrome
- Myofascial Pelvic Pain
Interventions
- DRUG
-
Bupivacaine
20 ML dose of 0.75% Bupivacaine Instillation (into bladder) 1 time during second study visit.
Sponsors & Collaborators
-
Case Western Reserve University
lead OTHER
Principal Investigators
-
Thomas C Chelimsky, MD · Medical College of Wisconsin
-
Jeffrey Janata, PhD · University Hospitals Cleveland Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
NCT04401176 ·Status: COMPLETED ·Phase: PHASE2
-
The Female Microbiome in Patients Undergoing Bladder Instillation Therapy
NCT05414305 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
NCT00775281 ·Status: COMPLETED
-
Interstitial Cystitis: Examination of the Central Autonomic Network
NCT03008382 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life Analysis in Bladder Pain Syndrome/Interstitial Cystitis
NCT05630742 ·Status: COMPLETED
-
Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis
NCT01138800 ·Status: COMPLETED
-
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
NCT02870738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Interstitial Cystitis (IC)-Like Findings With Hydrodistension
NCT02547298 ·Status: TERMINATED
-
Identifying Genetic Causes of IC/BPS
NCT00389142 ·Status: RECRUITING
-
Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
NCT00704457 ·Status: COMPLETED
-
Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
NCT02497976 ·Status: COMPLETED ·Phase: PHASE3
-
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
NCT05811377 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
NCT03619486 ·Status: COMPLETED ·Phase: NA
-
Relationship: Interstitial Cystitis & Vulvodynia-Part 2
NCT00751010 ·Status: COMPLETED
-
Clinical Trial Comparing Two Bladder Instillations for IC/BPS
NCT03463915 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
NCT05912946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis
NCT00823030 ·Status: WITHDRAWN ·Phase: NA
-
Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide
NCT05260112 ·Status: COMPLETED ·Phase: NA
-
Urinary Biomarkers Characteristic to Interstitial Cystitis
NCT00971568 ·Status: COMPLETED
-
A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
NCT01613586 ·Status: COMPLETED ·Phase: PHASE2
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
NCT04734847 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome
NCT04789135 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome
NCT04447729 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
NCT06729151 ·Status: RECRUITING
-
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
NCT00919113 ·Status: COMPLETED ·Phase: PHASE2